Cargando…
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism
Targeted molecular therapy is the most effective treatment for cancer. An effective therapeutic target for colorectal cancer (CRC) is urgently needed. However, the mechanisms of CRC remain poorly understood, which has hampered research and development of CRC-targeted therapy. TRIM29 is a ubiquitin E...
Autores principales: | Han, Jing, Zhao, Zitong, Zhang, Nan, Yang, Yang, Ma, Liying, Feng, Li, Zhang, Xue, Zuo, Jing, Fan, Zhisong, Wang, Yudong, Song, Yongmei, Wang, Guiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950264/ https://www.ncbi.nlm.nih.gov/pubmed/33495406 http://dx.doi.org/10.18632/aging.202414 |
Ejemplares similares
-
TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells
por: Yuan, Peng, et al.
Publicado: (2020) -
TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer
por: Han, Yudong, et al.
Publicado: (2020) -
TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma
por: Han, Yudong, et al.
Publicado: (2017) -
Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
por: Li, Aiyun, et al.
Publicado: (2018) -
TRIM29 in Cutaneous Squamous Cell Carcinoma
por: Hsu, Che-Yuan, et al.
Publicado: (2021)